With the aid of spatial transcriptomics and proteomics data, we confirmed that ISG15 is highly expressed and predominantly co-located with the myCAF subcluster in breast cancer, underlining its significant role in pro-tumor. The gene discussed is ISG15; the disease is breast carcinoma.